CA 50 Blood Test (Pancreatic & Digestive Cancer Marker)

CA 50 (cancer antigen 50) is a protein found in the blood that can be raised in certain conditions affecting the digestive system, particularly the pancreas and gastrointestinal tract. It is used as a tumour marker, mainly to help monitor known cancers rather than to detect them in the first place. It is closely related to CA 19.9 and the two often behave in a similar way.

What it can help assess

• Monitoring known gastrointestinal cancers, particularly those of the pancreas, stomach, and bowel, by tracking how levels change during and after treatment
• Supporting the wider investigation of digestive system conditions, alongside imaging and other tests
• Checking for recurrence in people already diagnosed and treated

An important note on interpretation

CA 50 is not a screening or diagnostic test for cancer. Levels can be normal in early disease, so a normal result does not rule cancer out, and it should never be used to detect cancer in someone without a diagnosis. Levels can also be raised by a number of non-cancerous conditions, including pancreatitis, liver disease, and other digestive or inflammatory conditions. For these reasons the result is always interpreted alongside your full clinical picture rather than on its own.

Why it matters

For people diagnosed with pancreatic or other gastrointestinal cancers, CA 50 can be a useful tool for monitoring the condition over time and assessing response to treatment. Any result should be discussed with your GP or specialist, who can interpret it in the context of your individual situation and advise on the appropriate next steps.